Panagora Asset Management Inc Eiger Bio Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.04 - $9.66 $2,881 - $4,607	477 Added 0.81%	59,313 $447,000
Q2 2022 Aug 15, 2022	SELL	$4.99 - $8.96 $3,468 - $6,227	-695 Reduced 1.17%	58,836 $371,000
Q4 2021 Feb 10, 2022	BUY	$5.12 - $8.19 $188,759 - $301,940	36,867 Added 162.67%	59,531 $309,000
Q3 2021 Nov 10, 2021	BUY	$6.68 - $9.1 $146,886 - $200,099	21,989 Added 3257.63%	22,664 $151,000
Q2 2021 Aug 11, 2021	BUY	$7.82 - $9.23 $5,278 - $6,230	675 New	675 $6,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.